130 related articles for article (PubMed ID: 22961594)
1. Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat.
Knapp M; Zendzian-Piotrowska M; Błachnio-Zabielska A; Zabielski P; Kurek K; Górski J
Basic Res Cardiol; 2012 Nov; 107(6):294. PubMed ID: 22961594
[TBL] [Abstract][Full Text] [Related]
2. Dihydrosphingosine driven enrichment of sphingolipids attenuates TGFβ induced collagen synthesis in cardiac fibroblasts.
Magaye RR; Savira F; Xiong X; Huynh K; Meikle PJ; Reid C; Flynn BL; Kaye D; Liew D; Wang BH
Int J Cardiol Heart Vasc; 2021 Aug; 35():100837. PubMed ID: 34277924
[TBL] [Abstract][Full Text] [Related]
3. Bioactive Sphingolipids, Complement Cascade, and Free Hemoglobin Levels in Stable Coronary Artery Disease and Acute Myocardial Infarction.
Jadczyk T; Baranski K; Syzdol M; Nabialek E; Wanha W; Kurzelowski R; Ratajczak MZ; Kucia M; Dolegowska B; Niewczas M; Zejda J; Wojakowski W
Mediators Inflamm; 2018; 2018():2691934. PubMed ID: 30116144
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between Serum and Skin Sphingolipids in Psoriasis.
Matwiejuk M; Myśliwiec H; Lukaszuk B; Lewoc M; Malla H; Myśliwiec P; Dadan J; Chabowski A; Flisiak I
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834321
[TBL] [Abstract][Full Text] [Related]
5. The effect of normobaric hypoxia on acute exercise-induced changes in blood sphingoid base-1-phosphates metabolism in cyclists.
Hodun K; Czuba M; Płoszczyca K; Sadowski J; Langfort J; Chabowski A; Baranowski M
Biol Sport; 2024 Mar; 41(2):37-45. PubMed ID: 38524828
[TBL] [Abstract][Full Text] [Related]
6. Alterations in urinary ceramides, sphingoid bases, and their phosphates among patients with kidney disease.
Morita Y; Sakai E; Isago H; Ono Y; Yatomi Y; Kurano M
Front Nephrol; 2024; 4():1343181. PubMed ID: 38504855
[TBL] [Abstract][Full Text] [Related]
7. Intestinal absorption of sphingosine: new insights on generated ceramide species using stable isotope tracing in vitro.
Calzada C; Cheillan D; Ritsch N; Vors C; Durand A; Pesenti S; Pettazzoni M; Meugnier E; Michalski MC; Penhoat A
J Lipid Res; 2024 May; ():100557. PubMed ID: 38719152
[TBL] [Abstract][Full Text] [Related]
8. Novel analogs of D-e-MAPP and B13. Part 2: signature effects on bioactive sphingolipids.
Bielawska A; Bielawski J; Szulc ZM; Mayroo N; Liu X; Bai A; Elojeimy S; Rembiesa B; Pierce J; Norris JS; Hannun YA
Bioorg Med Chem; 2008 Jan; 16(2):1032-45. PubMed ID: 17881234
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease manifests abnormal sphingolipid metabolism.
Uranbileg B; Isago H; Sakai E; Kubota M; Saito Y; Kurano M
Front Aging Neurosci; 2024; 16():1368839. PubMed ID: 38774265
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent effect of aspirin on the level of sphingolipids in human blood.
Knapp M; Lisowska A; Knapp P; Baranowski M
Adv Med Sci; 2013; 58(2):274-81. PubMed ID: 24101372
[TBL] [Abstract][Full Text] [Related]
11. Sustained decrease in plasma sphingosine-1-phosphate concentration and its accumulation in blood cells in acute myocardial infarction.
Knapp M; Lisowska A; Zabielski P; Musiał W; Baranowski M
Prostaglandins Other Lipid Mediat; 2013 Oct; 106():53-61. PubMed ID: 24120760
[TBL] [Abstract][Full Text] [Related]
12. Circulating Sphingolipids in Insulin Resistance, Diabetes and Associated Complications.
Hammad SM; Lopes-Virella MF
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762318
[TBL] [Abstract][Full Text] [Related]
13. Potential Drug Targets for Ceramide Metabolism in Cardiovascular Disease.
Guo J; Feng J; Qu H; Xu H; Zhou H
J Cardiovasc Dev Dis; 2022 Dec; 9(12):. PubMed ID: 36547431
[TBL] [Abstract][Full Text] [Related]
14. Sphingolipid metabolism and signaling in cardiovascular diseases.
Borodzicz-Jażdżyk S; Jażdżyk P; Łysik W; Cudnoch-Jȩdrzejewska A; Czarzasta K
Front Cardiovasc Med; 2022; 9():915961. PubMed ID: 36119733
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine-1-phosphate interactions in the spleen and heart reflect extent of cardiac repair in mice and failing human hearts.
B Gowda S; Gowda D; Kain V; Chiba H; Hui SP; Chalfant CE; Parcha V; Arora P; Halade GV
Am J Physiol Heart Circ Physiol; 2021 Sep; 321(3):H599-H611. PubMed ID: 34415189
[TBL] [Abstract][Full Text] [Related]
16. Cardiac phospholipidome is altered during ischemia and reperfusion in an ex vivo rat model.
Montero-Bullon JF; Aveiro SS; Melo T; Martins-Marques T; Lopes D; Neves B; Girão H; Rosário M Domingues M; Domingues P
Biochem Biophys Rep; 2021 Sep; 27():101037. PubMed ID: 34169155
[TBL] [Abstract][Full Text] [Related]
17. Narrative review of metabolomics in cardiovascular disease.
Müller J; Bertsch T; Volke J; Schmid A; Klingbeil R; Metodiev Y; Karaca B; Kim SH; Lindner S; Schupp T; Kittel M; Poschet G; Akin I; Behnes M
J Thorac Dis; 2021 Apr; 13(4):2532-2550. PubMed ID: 34012599
[TBL] [Abstract][Full Text] [Related]
18. Integrated Network Pharmacology and Metabonomics to Reveal the Myocardial Protection Effect of Huang-Lian-Jie-Du-Tang on Myocardial Ischemia.
Li L; Dai W; Li W; Zhang Y; Wu Y; Guan C; Zhang A; Huang H; Li Y
Front Pharmacol; 2020; 11():589175. PubMed ID: 33613277
[TBL] [Abstract][Full Text] [Related]
19. Blood bioactive sphingolipids in patients with advanced serous epithelial ovarian cancer - mass spectrometry analysis.
Knapp P; Bodnar L; Błachnio-Zabielska A; Reszeć J; Świderska M; Chabowski A
Arch Med Sci; 2021; 17(1):53-61. PubMed ID: 33488856
[TBL] [Abstract][Full Text] [Related]
20. Endothelial S1P
Nitzsche A; Poittevin M; Benarab A; Bonnin P; Faraco G; Uchida H; Favre J; Garcia-Bonilla L; Garcia MCL; Léger PL; Thérond P; Mathivet T; Autret G; Baudrie V; Couty L; Kono M; Chevallier A; Niazi H; Tharaux PL; Chun J; Schwab SR; Eichmann A; Tavitian B; Proia RL; Charriaut-Marlangue C; Sanchez T; Kubis N; Henrion D; Iadecola C; Hla T; Camerer E
Circ Res; 2021 Feb; 128(3):363-382. PubMed ID: 33301355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
